Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549

Neeta Solanki; Meenu Mehta; Dinesh Kumar Chellappan; Gaurav Gupta; Nicole G. Hansbro; Murtaza M. Tambuwala; Alaa Aa Aljabali; Keshav Raj Paudel; Gang Liu; Saurabh Satija; Philip M. Hansbro; Kamal Dua; Harish Dureja

doi:10.4155/fmc-2020-0083

Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549

Neeta Solanki, Meenu Mehta, Dinesh Kumar Chellappan, Gaurav Gupta, Nicole G. Hansbro, Murtaza M. Tambuwala, Alaa Aa Aljabali, Keshav Raj Paudel, Gang Liu, Saurabh Satija, Philip M. Hansbro, Kamal Dua, Harish Dureja

Research output: Contribution to journal › Article › peer-review

31 Citations (Scopus)

7 Downloads (Pure)

Abstract

Aim: In the present study boswellic acids-loaded chitosan nanoparticles were synthesized using ionic gelation technique. The influence of independent variables were studied and optimized on dependent variables using central composite design. Methodology & results: The designed nanoparticles were observed spherical in shape with an average size of 67.5-187.2 nm and have also shown an excellent entrapment efficiency (80.06 ± 0.48). The cytotoxicity assay revealed enhanced cytotoxicity for drug-loaded nanoparticles in contrast to the free drug having an IC50 value of 17.29 and 29.59 μM, respectively. Flow cytometry confirmed that treatment of cells with 40 μg/ml had arrested 22.75 ± 0.3% at SubG0 phase of the cell cycle when compared with untreated A459 cells. The observed results justified the boswellic acids-loaded chitosan nanoparticles were effective due to greater cellular uptake, sustained intercellular drug retention and enhanced antiproliferative effect by inducing apoptosis.

Original language	English
Pages (from-to)	2019-2034
Number of pages	16
Journal	Future Medicinal Chemistry
Volume	12
Issue number	22
Early online date	30 Oct 2020
DOIs	https://doi.org/10.4155/fmc-2020-0083 https://doi.org/https://www.future-science.com/doi/full/10.4155/fmc-2020-0083
Publication status	Published (in print/issue) - 30 Nov 2020

Bibliographical note

Funding Information:
The authors are thankful to the Graduate School of Health, University of Technology Sydney, Australia. M Mehta is supported by the University of Technology Sydney International Research Training Program Scholarship (IRTP) and International Research Training Program Scholarship (IRTP). K Dua is supported by a project grant from Rebecca L Cooper Medical Research Foundation and Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) for the TRIPLE I CAG Secondment/Exchange grant. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Publisher Copyright:
© 2020 Future Medicine Ltd.. All rights reserved.

Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.

Keywords

bioavailability
boswellic acids
chitosan
lung cancer
nanoparticles

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

FMC paper revisedAuthor Accepted Manuscript, 937 KB

https://pubmed.ncbi.nlm.nih.gov/33124483/

Cite this

Solanki, N., Mehta, M., Chellappan, D. K., Gupta, G., Hansbro, N. G., Tambuwala, M. M., Aa Aljabali, A., Paudel, K. R., Liu, G., Satija, S., Hansbro, P. M., Dua, K., & Dureja, H. (2020). Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549. Future Medicinal Chemistry, 12(22), 2019-2034. https://doi.org/10.4155/fmc-2020-0083, https://doi.org/https://www.future-science.com/doi/full/10.4155/fmc-2020-0083

@article{df21fce17e22437ab5eee47bc8e5b9b1,

title = "Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549",

abstract = "Aim: In the present study boswellic acids-loaded chitosan nanoparticles were synthesized using ionic gelation technique. The influence of independent variables were studied and optimized on dependent variables using central composite design. Methodology & results: The designed nanoparticles were observed spherical in shape with an average size of 67.5-187.2 nm and have also shown an excellent entrapment efficiency (80.06 ± 0.48). The cytotoxicity assay revealed enhanced cytotoxicity for drug-loaded nanoparticles in contrast to the free drug having an IC50 value of 17.29 and 29.59 μM, respectively. Flow cytometry confirmed that treatment of cells with 40 μg/ml had arrested 22.75 ± 0.3% at SubG0 phase of the cell cycle when compared with untreated A459 cells. The observed results justified the boswellic acids-loaded chitosan nanoparticles were effective due to greater cellular uptake, sustained intercellular drug retention and enhanced antiproliferative effect by inducing apoptosis.",

keywords = "bioavailability, boswellic acids, chitosan, lung cancer, nanoparticles",

author = "Neeta Solanki and Meenu Mehta and Chellappan, {Dinesh Kumar} and Gaurav Gupta and Hansbro, {Nicole G.} and Tambuwala, {Murtaza M.} and {Aa Aljabali}, Alaa and Paudel, {Keshav Raj} and Gang Liu and Saurabh Satija and Hansbro, {Philip M.} and Kamal Dua and Harish Dureja",

note = "Funding Information: The authors are thankful to the Graduate School of Health, University of Technology Sydney, Australia. M Mehta is supported by the University of Technology Sydney International Research Training Program Scholarship (IRTP) and International Research Training Program Scholarship (IRTP). K Dua is supported by a project grant from Rebecca L Cooper Medical Research Foundation and Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) for the TRIPLE I CAG Secondment/Exchange grant. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Publisher Copyright: {\textcopyright} 2020 Future Medicine Ltd.. All rights reserved. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = nov,

day = "30",

doi = "10.4155/fmc-2020-0083",

language = "English",

volume = "12",

pages = "2019--2034",

journal = "Future Medicinal Chemistry",

issn = "1756-8919",

publisher = "Future Science",

number = "22",

}

Solanki, N, Mehta, M, Chellappan, DK, Gupta, G, Hansbro, NG, Tambuwala, MM, Aa Aljabali, A, Paudel, KR, Liu, G, Satija, S, Hansbro, PM, Dua, K & Dureja, H 2020, 'Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549', Future Medicinal Chemistry, vol. 12, no. 22, pp. 2019-2034. https://doi.org/10.4155/fmc-2020-0083, https://doi.org/https://www.future-science.com/doi/full/10.4155/fmc-2020-0083

TY - JOUR

T1 - Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549

AU - Solanki, Neeta

AU - Mehta, Meenu

AU - Chellappan, Dinesh Kumar

AU - Gupta, Gaurav

AU - Hansbro, Nicole G.

AU - Tambuwala, Murtaza M.

AU - Aa Aljabali, Alaa

AU - Paudel, Keshav Raj

AU - Liu, Gang

AU - Satija, Saurabh

AU - Hansbro, Philip M.

AU - Dua, Kamal

AU - Dureja, Harish

N1 - Funding Information: The authors are thankful to the Graduate School of Health, University of Technology Sydney, Australia. M Mehta is supported by the University of Technology Sydney International Research Training Program Scholarship (IRTP) and International Research Training Program Scholarship (IRTP). K Dua is supported by a project grant from Rebecca L Cooper Medical Research Foundation and Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) for the TRIPLE I CAG Secondment/Exchange grant. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Publisher Copyright: © 2020 Future Medicine Ltd.. All rights reserved. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/11/30

Y1 - 2020/11/30

N2 - Aim: In the present study boswellic acids-loaded chitosan nanoparticles were synthesized using ionic gelation technique. The influence of independent variables were studied and optimized on dependent variables using central composite design. Methodology & results: The designed nanoparticles were observed spherical in shape with an average size of 67.5-187.2 nm and have also shown an excellent entrapment efficiency (80.06 ± 0.48). The cytotoxicity assay revealed enhanced cytotoxicity for drug-loaded nanoparticles in contrast to the free drug having an IC50 value of 17.29 and 29.59 μM, respectively. Flow cytometry confirmed that treatment of cells with 40 μg/ml had arrested 22.75 ± 0.3% at SubG0 phase of the cell cycle when compared with untreated A459 cells. The observed results justified the boswellic acids-loaded chitosan nanoparticles were effective due to greater cellular uptake, sustained intercellular drug retention and enhanced antiproliferative effect by inducing apoptosis.

AB - Aim: In the present study boswellic acids-loaded chitosan nanoparticles were synthesized using ionic gelation technique. The influence of independent variables were studied and optimized on dependent variables using central composite design. Methodology & results: The designed nanoparticles were observed spherical in shape with an average size of 67.5-187.2 nm and have also shown an excellent entrapment efficiency (80.06 ± 0.48). The cytotoxicity assay revealed enhanced cytotoxicity for drug-loaded nanoparticles in contrast to the free drug having an IC50 value of 17.29 and 29.59 μM, respectively. Flow cytometry confirmed that treatment of cells with 40 μg/ml had arrested 22.75 ± 0.3% at SubG0 phase of the cell cycle when compared with untreated A459 cells. The observed results justified the boswellic acids-loaded chitosan nanoparticles were effective due to greater cellular uptake, sustained intercellular drug retention and enhanced antiproliferative effect by inducing apoptosis.

KW - bioavailability

KW - boswellic acids

KW - chitosan

KW - lung cancer

KW - nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=85096152184&partnerID=8YFLogxK

U2 - 10.4155/fmc-2020-0083

DO - 10.4155/fmc-2020-0083

M3 - Article

C2 - 33124483

AN - SCOPUS:85096152184

VL - 12

SP - 2019

EP - 2034

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 22

ER -

Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this